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with DAPT > 12 months were older, more often had history of hy-
pertension, diabetes and chronic kidney disease and were more likely
to have presented with non-ST-elevated myocardial infarction and
left ventricular dysfunction, treated with more drug-eluting stents
(DES) with longer stent length and stent size. In multivariable models,
variation of centers, age (risk ratio [RR] 1.01, 95% conﬁdence interval
[CI] 1.00 to 1.02, p<0.001), history of chronic kidney disease (RR1.73,
95%CI 1.02 to 2.95, p¼0.042) and numbers of DES implantation per
patient (RR1.14, 95%CI1.02 to 1.28, p¼0.021) were independent pre-
dictors of extended DAPT beyond 12 months.
CONCLUSIONS Almost half of patients after stent deployment
continued DAPT beyond 12 months. Prolonged DAPT was associated
with a high incidence of comorbidities and complex intervention as
well as signiﬁcant region variation.
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OBJECTIVES Coronary artery diseases (CAD) is one of the most
common and serious cardiovascular diseases. Studies have shown
that lncRNA closely associated with a number of human diseases,
including CAD. However, the potential functional role of lncRNAs in
CAD remains unclear. We identiﬁed LncRNA-AC100865.1(LncRNA-
CAD) and miR-205-5p. Here, we tested the hypothesis that LncRNA-
CAD and miR-205-5p can participate in the regulation of CAD in vivo
and in vitro.
METHODS A microarray was performed to discovery LncRNA-CAD
and miR-205-5p. Then, a real-time ﬂuorescence quantitative PCR was
used to verify this results. Luciferase reporter was performed to verify
the direct binding site for LncRNA-CAD and miR-205-5p.
RESULTS According to microarray and Q-PCR, compared with con-
trols, LncRNA-CAD and miR-205-5p were signiﬁcantly upregulated in
the plasma of patients with AS. The results from loss and gain func-
tion of LncRNA-CAD indicated that LncRNA-CAD could promote the
expression of miR-205-5p. And PTEN was identiﬁed as a miR-205-5p
target gene to mediate the function of miR-205-5p in AS. By knock-
down the expression of PTEN in HUVECs, it showed enhanced
inﬂammation responses. Further, we investigated the molecular
mechanism by which LncRNA-CAD expression is regulated, Bioinfor-
matics analysis was performed to ﬁnd LncRNA-CAD and miR-205-5p
have potential binding sites and conﬁrmed through luciferase re-
porter, and found that LncRNA-CAD could directly bind to the pro-
moter of miR-205-5p, and regulate the expression of PTEN in the CAD.
CONCLUSIONS Our study reveals a novel CAD regulating model
which is composed of LncRNA-CAD, miR-205-5p and PTEN. Modula-
tion of their levels may provide a new approach for tackling CAD.
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Incidence Predictors Of Discontinued Dual Antiplatelet Therapy Among
Patients After Percutaneous Coronary Intervention
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OBJECTIVES Dual antiplatelet therapy (DAPT) cessation increases the
risk of adverse events after percutaneous coronary intervention (PCI).
The present study sought to elucidate the frequency and predictors of
discontinued DAPT (duration shorter than 6 months) after stent
deployment in Chinese population.
METHODS We examined the incidence of discontinued DAPT within 6
months among patients after successful PCI enrolled in a 28-site
Chinese registry. Predictors of prolonged DAPT beyond 12 months
were evaluated using multivariable cox proportional hazards model.
RESULTS Among 3,102 patients, DAPT cessation was in 6.9% (n¼214)
within 6 months after PCI procedure. There was a signiﬁcant hetero-
geneity of DAPT duration among centers. Compared to those without
DAPT discontinuation (duration  6 months), patients with DAPT
discontinued were older, less often had history of hyperlipidemia, and
were more likely to have presented with higher incidence of left
ventricular dysfunction and lower hemoglobin level, underwent
more emergent PCI procedure with increasing number of longerdrug-eluting stents (DES). In multivariable models, variation of cen-
ters, history of dyslipidemia (RR 0.68, 95%CI 0.50 to 0.93, p¼0.014),
hemoglobin level (RR 0.98, 95%CI 0.97 to 0.99, p<0.001) and total
amounts of DES deployment (RR0.64, 95%CI 0.54 to 0.76, p<0.001)
were independent predictors of DAPT cessation< 6 months.
CONCLUSIONS Only less than 7% of patients discontinued DAPT
within 6 months after stent deployment. DAPT cessation was associ-
ated with signiﬁcant region variation, low incidence of comorbidities
and less complex intervention.
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Receptor and the Stenosis of the Coronary Artery in Patients with Coronary
Heart Disease
Zhenda Zheng, Cailian Cheng, Lin Wu, Dinghui Liu, Zhiming Song,
Lin Chen, Xiaoxian Qian
The Third Afﬁliated Hospital, SUN Yat-sen University, Guangzhou
510630, China
OBJECTIVES We investigated the change of u-PA and its receptor in
different types of the CHD. With the results of coronary artery angi-
ography, we discussed the relationship between the results of coro-
nary artery angiography and the levels of u-PA, u-PAR, to uncover the
clinic role of u-PA, u-PAR in the patients with coronary heart disease.
METHODS We divide all the cases into 4 groups: 30 cases in NCAD
group, 20 patients in SA group, 25 patients in UA group, 30 patients in
AMI group. In all these groups, we measured the expression of u-PAR
on neutrophile with ﬂow cytometry and measured the levels of u-PA
in plasma with a solid phase enzyme-linked immuneosorbent assay
(ELISA) and analysis the relationship between the results of coronary
artery angiography and the levels of u-PA, u-PAR.
RESULTS All the samples taken from the coronary artery in this 4
groups were analyzed. The difference between the expression levels
of u-PAR on neutrophile and the plasma levels of u-PA was signiﬁcant,
the AMI group were higher than the UA group[(69.075.92)%
vs.(51.053.15)%, (0.810.11) mg/L vs. (0.500.05) mg/L, P<0.001];
the UA group were higher than the SA group[(51.053.15% vs.
(30.374.77)%, (0.500.05) mg/L vs. (0.360.04) mg/L,P<0.001]; but
the different between the SA group and the NCAD group was not
signiﬁcant[(30.374.77)% vs. (30.024.65)%, (0.360.04) mg/L vs.
(0.300.03) mg/L, P>0.05]. Compared the samples taken from the
peripheral vessel with the samples taken from the coronary artery, the
difference between the plasma levels of u-PA and the expression
levels of u-PAR on neutrophile was not signiﬁcant (0.0030.002,
P>0.05; -0.120.099, P>0.05). In the samples taken from the coronary
artery, the plasma levels of u-PA and the expression of u-PAR on
neutrophile were all signiﬁcantly related to Jenkins score (r1¼0.943,
P<0.001; r2¼0.814, P<0.001).
CONCLUSIONS We may predict the severity of the pathological
change of the coronary artery through measured the levels of u-PA in
the plasma or the expressions of u-PAR in neutrophile which taken
from the peripheral vessel.
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OBJECTIVES Coronary artery calciﬁcation (CAC) is associated with
greater risk of mortality in elderly individuals. Basic researches have
indicated that bone morphogenetic proteins (BMPs) might activate
coronary artery smooth muscle cell calciﬁcation. However, the pre-
dictive values of serum BMPs for the progression of CAC remain un-
certain. We aimed to assess the values of serum BMP-2, BMP-4 and
BMP-7 for predicting the CAC in the elderly.
METHODS The present study was performed in 573 subjects  65y
undergoing 64 or 320-slice coronary computed tomography angiog-
raphy (CCTA). CAC was evaluated by the Agatston calcium score
determined by CCTA. Serum levels of BMP-2, BMP-4 and BMP-7 were
measured using the appropriate ELISA kits. Correlations between CAC
and BMPs were assessed by Pearson correlation analysis. Multivariate
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of serum BMPs.
RESULTS Subjects with Agatston score  400 (n¼254) had higher
serum levels of BMP-2 (116.3 12.5pg/ml vs. 87.8 10.7pg/ml,
p<0.001), BMP-4 (91.2 9.7pg/ml vs. 73.28.7pg/ml, p¼0.017) and
BMP-7 (91.2 8.3pg/ml vs. 51.3 5.9pg/ml, p<0.001) than those
with Agatston score < 400 (n¼319). Agatston scores were posi-
tively correlated with the serum levels of BMP-2 (r¼0.624, p<0.001),
BMP-4 (r¼0.503, p<0.001) and BMP-7(r¼0.662, p<0.001). After
adjustment for other risk factors, multivariate logistic regres-
sion analysis considered that increased serum levels of BMP-2
[OR:1.646(1.125,3.073), p<0.001], BMP-4 [OR:1.243(1.033,3.135),
p¼0.023] and BMP-7 [OR:2.085(1.376,3.598), p<0.001] were indepen-
dent predictors for the progression of CAC.
CONCLUSIONS Serum BMP-2, BMP-4 and BMP-7 can predict the CAC
in the elderly.
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OBJECTIVES To uncover the value of Soluble urokinase-type plas-
minogen activator receptor (su-PAR) in predicting major adverse
cardiovascular events (MACE) among patients with acute coronary
syndrome (ACS) undergoing percutaneous coronary intervention
(PCI).
METHODS A total of 103 patients with ACS undergoing PCI in Cardi-
ology Department of SUN Yat-sen University The Third Afﬁliated
Hospital between June 2005 to August 2006 were enrolled. In all these
patients, we measured the lever of su-PAR in plasma with a solid
phaseenzyme-linked immuneosorbent assay (ELISA) when the cases
were brought into this study and two weeks after they were brought
into this study. We divided all the cases into three groups according to
the u-PAR. The end points were all-cause mortality and fatal or
nonfatal recurrent myocardial infarction (MI).
RESULTS During a median follow-up period of 7 years, 13 deaths and 3
fatal and 11 nonfatal recurrent MIs occurred. MACE rates of low, in-
termediate, and high tertiles according to the su-PAR were 12.1%,
20.0% and 31.4%, respectively. Both univariate analysis and multi-
variate analysis showed that the su-PAR was the independent pre-
dictor of MACE (HR¼2.28, 95%CI (1.41, 3.39), P¼0.002; HR¼2.16, 95%
CI (1.32, 3.38), P¼0.005).
CONCLUSIONS Urokinase-type plasminogen activator receptor could
be a independent risk predictor of major adverse cardiovascular
events among patients with acute coronary syndrome undergoing
percutaneous coronary intervention.
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OBJECTIVES To ﬁnd the relationship between different levels of
glycosylated hemoglobin and severity of coronary artery lesions in
patients with coronary heart disease and type 2 diabetes mellitus.
METHODS We collected the data of 184 patients with coronary heart
disease and type 2 diabetes mellitus. Then the patients were divided
into three groups based on glycosylated hemoglobin levels including
group A (n¼70, HbA1C7.0%), group B (n¼37, 7.0%<HbA1C<8.0%),
and group C (n¼77, HbA1C8.0%). Gensini score was used to assess
the severity of coronary lesions by coronary angiography. All statis-
tical tests were operated with program SPSS13.0 and P<0.05 was
considered statistically signiﬁcant.
RESULTS (1) The incidence of left main lesions was 7.1%, 2.7%, and
10.4% in group A, group B, group C, respectively. The prevalence of
diffuse lesions in each group was 32.9%, 24.3%, and 26.0%, respec-
tively. The prevalence of complete occlusive lesions in each groupwas 28.6%, 27.0%, and 27.3%, respectively. There were no sig-
niﬁcant differences in the left main lesions, diffuse lesions, and
complete occlusive lesions between three groups (P>0.05). (2) The
median of Gensini score of threegroups was 57.75, 56.00, 46.00,
respectively. By square root transformation, all the ratios of the
Gensini score are normal distribution, One-way ANOVA was used as
appropriate to compare means among different groups, and the re-
sults show no signiﬁcant differences between the three groups
(P>0.05).
CONCLUSIONS Among patients with coronary heart disease and type
2 diabetes mellitus, there was no signiﬁcant correlation between
glycosylated hemoglobin and severity of coronary artery lesions.
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Correlation between clopidogrel low response and CYP2C19 gene
polymorphism in CAD patients after PCI
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OBJECTIVES To explore the correlation between clopidogrel low
response and CYP2C19 gene polymorphism in coronary artery disease
(CAD) patients after percutaneous coronary intervention (PCI ).
METHODS A total of 200 patients with CAD after PCI are admitted to
our hospital from October 2013 to October 2014 in this study, and
treated with dual antiplatelet drugs, aspirin and clopidogrel. The
clopidogrel response is judged by depending on the ADP-induced
platelet inhibition rate tested by thromboelastogram. In this study the
ADP-induced platelet inhibition rate less than 30% is deﬁned as clo-
pidogrel low response and the gene chip detection technology is used
to detect the genotype of CYP2C19 to further explore the correlation
between clopidogrel low response and CYP2C19 gene polymorphism
in CAD patients after PCI.
RESULTS In these 200 patients, the ADP-induced platelet inhibition
rate is signiﬁcantly statistical difference between patients carrying
CYP2C19*1/*1 and CYP2C19*1/*2, CYP2C19*1/*1 and CYP2C19*2/*2. The
total occurrence of clopidogrel low response is 39.5%(79 patients).
There is signiﬁcant difference between clopidogrel low response and
CYP2C19 genotyes, metabolizers, indicating that less patients with
extensive metabolizer (CYP2C19*1/*1) in the clopidogrel response
group, more patients with intermediate or poor metabolizers in the
clopidogrel low response group.
CONCLUSIONS There is correlation between clopidogrel low response
and CYP2C19 gene polymorphism in patients with CAD, more carriers
with intermediate or poor metabolizers in the clopidogrel low
response group.
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Non-alcoholic fatty liver disease affects the relationship between
epicardium and coronary atherosclerotic heart disease
He Cai, Shouyan Hao, Yang Zheng
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OBJECTIVES To explore the relationship between the various parts of
the visceral fat (VF) and coronary atherosclerotic heart disease (CAD),
and to ﬁnd whether Non-alcoholic fatty liver disease (NAFLD) affects
the correlation between VF and CAD. The results can provide a new
reference index for the prevention, prediction, treatment and reha-
bilitation of CAD.
METHODS This study selected 339 patients, We used ultrasonography
to measure the thickness of various parts VF and NAFLD. According to
the results of coronary angiography, we determined the patients with
CAD and used Gensini value to evaluate the extent of lesion. Firstly,
according to the results of coronary angiography, the patients were
divided into CAD group and non CAD group to determine whether the
VF, NAFLD are the independent risk factors for CAD. Secondly, ac-
cording to Gensini value, the patients were divided into three groups
to investigate whether there is a relationship between VF and the
severity of CAD. Finally, the CAD patients were divided into NAFLD
group and non NAFDL group to determine the relationship between
NAFLD and VF, and the inﬂuence of NAFLD on the relationship be-
tween VF and CAD.
RESULTS Using the single factor analysis, we found that epicardium,
NAFLD, smoking, high blood pressure, HDL-C, LDL-C, TG in CAD
group were signiﬁcantly higher than those in non-CAD group
(P<0.05). There was no signiﬁcant difference between the two groups
